HarmoniaMentis Sverige

F98bdda8e6a0be36f2406e9fef238f570c09c962

Welcome to
Harmoniamentis

Epilepsy impacts every aspect of life for patients and their loved ones. At HarmoniaMentis.se, Angelini Pharma offers a trusted platform with guidance, articles, videos, and practical information. Healthcare professionals can also access scientific resources to stay informed and support their patients.

  1. ONTOZRY®

    ONTOZRY® (cenobamate) is an anti-epileptic medicine used to treat focal seizures in adults.1 Discover its mechanism of action, dosing, clinical efficacy, safety profile, and drug interactions.

     

    EXPLORE MORE

About Epilepsy

Epilepsy is one of the most prevalent brain disorders, affecting over 50 million people worldwide.2 Defined by recurrent unprovoked seizures3, it can stem from genetic, structural, metabolic, or unknown causes.4 While antiseizure medications provide effective treatment for many, about one-third of patients face drug-resistant epilepsy.5 Accurate diagnosis and individualized care are essential to improving outcomes.5

Harmoniamentis Doctor

Clinical Insights

Stay up-to-date with the latest research and clinical findings on epilepsy and its treatment strategies.

Medical Lounge

Looking for in-depth resources focused on Epilepsy and the Central Nervous System (CNS)? Step into the Medical Lounge
 – your hub for scientific content, educational materials, and patient support, designed exclusively for healthcare professionals.

Living with epilepsy

Epilepsy education

Explore educational resources arranged by Angelini to support HCPs and the epilepsy community. Access the latest insights in epilepsy management, including focal seizures, and discover content for those unable to attend live sessions.

    1. Produktresumé Ontozry
    2. World Health Organization. Epilepsy Fact Sheet. WHO. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/epilepsy
    3. Beghi E, Giussani G, Sander JW. The natural history and prognosis of epilepsy. Epileptic Disord. 2015;17(3):243-53.
    4. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521.
    5. Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689-701.
MAT-SE-0042-P 6.10.2025

spacer

Contact Us

Have a question or want to connect? Find all the ways to connect with Angelini Pharma on our contact page.

Don't miss out!

Would you like to receive news, congress reports, and invitations to lectures on epilepsy and epilepsy treatments?

Denna webbsajt är avsedd för vårdpersonal i Sverige. Är du vårdpersonal?